Allcutis Research, Inc.

Beverly, Massachusetts 01915

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Hidradenitis Suppurativa

Studies at this site

• A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color — Completed
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab — Completed
• A Study of LY3041658 in Adults With Hidradenitis Suppurativa — Completed